[1]
2017. [Nintedanib for the treatment of idiopathic pulmonary fibrosis in Italy]. Farmeconomia. Health Economics and Therapeutic Pathways. 18, 1S (Apr. 2017). DOI:https://doi.org/10.7175/fe.v18i1S.1300.